Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multi-Centre Registry of EvroSure (Everolimus Drug Eluting CoCr Coronary Stent) to Investigate Safety and Effectiveness Name of Study: EverGreen

NCT06769217 is registered in ClinicalTrials.gov with Frisch Medical Device Private Limited as lead sponsor.

NCT NCT06769217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06769217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multi-Centre Registry of EvroSure (Everolimus Drug Eluting CoCr Coronary Stent) to Investigate Safety and Effectiveness Name of Study: EverGreen
Lead sponsor
Frisch Medical Device Private Limited
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2023
Completion date
January 30, 2025
Enrollment
888 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

coronary arterial disease (cad)